Galmed Pharmaceuticals Ltd.
GLMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,517 | -$6,912 | -$17,866 | -$32,467 |
| Dep. & Amort. | $83 | $31 | $35 | $42 |
| Deferred Tax | $0 | $0 | $0 | $84 |
| Stock-Based Comp. | $531 | $892 | $1,296 | $1,886 |
| Change in WC | -$728 | $132 | -$2,451 | -$2,450 |
| Other Non-Cash | $1,751 | -$280 | $485 | $13 |
| Operating Cash Flow | -$5,880 | -$6,137 | -$18,501 | -$32,892 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$4 | -$11 |
| Net Acquisitions | $0 | -$1,500 | -$18 | $0 |
| Inv. Purchases | -$6,365 | -$6,333 | -$3,873 | -$13,569 |
| Inv. Sales/Matur. | $5,504 | $8,633 | $21,440 | $25,043 |
| Other Inv. Act. | -$250 | $0 | $18 | -$1 |
| Investing Cash Flow | -$1,111 | $800 | $17,563 | $11,462 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $8,786 | $6,185 | $70 | $17,368 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $8,786 | $6,185 | $70 | $17,368 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,795 | $848 | -$868 | -$4,062 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,978 | $2,130 | $2,998 | $7,060 |
| End Cash | $4,773 | $2,978 | $2,130 | $2,998 |
| Free Cash Flow | -$5,880 | -$6,137 | -$18,505 | -$32,903 |